gadopiclenol
Various (V08)US regulatory status: approved. Mechanism: Diagnostic agent.
- Mechanism
- Diagnostic agent
pharma · Primary Brain Tumor · Hepatocellular Carcinoma
Guerbet
Guerbet drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
VILLEPINTE, FR HQ
1926 Founded
2,465 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- VILLEPINTE, FR
- Founded
- 1926
- Employees
- 2,465
- Programs
- 4
- Drugs
- 5
- Patents
- 0
Guerbet pipeline
Portfolio lens on 5 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Guerbet drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved. Mechanism: Diagnostic agent.
- Mechanism
- Diagnostic agent
-
US regulatory status: approved. Mechanism: Unknown.
- Mechanism
- Unknown
-
Development asset linked to Guerbet in public FDA and regional records.
-
Development asset linked to Guerbet in public FDA and regional records.